PPN Awards Funding to Develop and Evaluate PANS/PANDAS Clinical Assessment

January 01, 2025 04:32 AM AEDT | By EIN Presswire

Google News:

PPN Awards Funding to Develop and Evaluate PANS/PANDAS Clinical Assessment — Image source: EIN Presswire

Recent News

Ausgold’s 10-Year Katanning Plan Shines in DFS: What it Means for Gold...

Western Mines Reignites Mulga Tank Drilling Program Amid Promising Res...

Great Boulder Resources Expands Market Footprint with New ASX Quotatio...

Lodestar Minerals Sees Surge on Successful Capital Raise Amid ASX Buzz

MOORESVILLE, NC, UNITED STATES, December 31, 2024 /EINPresswire.com/ -- PANDAS Physicians Network (PPN) is proud to award $50,000 to Dr. Lauren Breithaupt, Assistant Professor, Director Peripheral-brain Interactions Neuropsychiatry Center at Harvard Medical School, for her work in the development and evaluation of a clinical assessment of Pediatric Autoimmune and Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS).

Dr. Breithaupt’s work will fill a vital gap in the current diagnostic process by providing standard guidelines for assessing current PANS/PANDAS criteria and establishing the severity and clinical features of immune mediated neuroinflammatory brain disorders triggered by infections in both children and adults.

The development of a structured and comprehensive measure for PANS and PANDAS will benefit families, clinicians, and researchers. It provides families a pathway to an accurate diagnosis, which will reduce the time between symptom onset and recovery. For primary care providers, it aids in determining the best treatment options for their patients. Furthermore, it advances research by providing a standardized way to define the PANS/PANDAS population. This can accelerate the development of effective treatments and interventions, as researchers will have a more consistent population to study.

This project represents a new partnership between Harvard Medical School and Stanford University, with Dr. Breithaupt collaborating with Jennifer Frankovich, MD and Allison Vreeland, PhD.

Dr. Breithaupt has expertise in both eating disorders and obsessive compulsive disorder, including individuals with PANS/PANDAS. She is a clinical psychologist and neuroscientist whose research focuses on understanding how changes in the peripheral body impact the brain and central nervous system and contribute to the development and maintenance of psychiatric disease.

PANDAS Physicians Network (PPN) is a non-profit organization that provides PANS/PANDAS resources to clinicians while supporting research. Our vision is that PANS/PANDAS will become easily diagnosed and treated with accessible therapies that dramatically reduce suffering and lead to a cure. www.pandasppn.org

Media Relations
PANDAS Physicians Network
[email protected]
Visit us on social media:
Facebook
X
Instagram
YouTube
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.